Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Siebert U et al. - Administering GUIDE should allow tailoring treatment efficiently to genotype, bodyweight and early viral response in patients with chronic hepatitis C, and appears cost effective compared with other well accepted medical interventions.

Related Articles

Sporadic cases of acute autochthonous hepatitis E virus infection in Southwest Germany
Journal of Clinical Virology, 11/16/09    Relevance Score: 91%

Liver enzyme abnormalities in systemic lupus erythematosus: A focus on toxic hepatitis
Rheumatology International, 11/13/09    Relevance Score: 91%

De novo hepatocellular carcinoma in a liver graft with sustained hepatitis C virus clearance after living donor liver transplantation
Liver Transplantation, 10/30/09    Relevance Score: 91%

Reactivation of Hepatitis B With Reappearance of Hepatitis B Surface Antigen After Chemotherapy and Immunosuppression
Clinical Gastroenterology and Hepatology, 10/09/09    Relevance Score: 91%

FOXP3 Expression in Hepatitis C Virus-Specific CD4+ T Cells During Acute Hepatitis C
Gastroenterology, 10/06/09    Relevance Score: 91%

Today in Pharmacoeconomics...keeping you current

Cost-effectiveness of single agent, uptitration and switching statin treatment strategies for lipid lowering in Sweden
Current Medical Research and Opinion, 12/14/09

Hospital visits and costs following outpatient treatment of CAP with levofloxacin or moxifloxacin
Current Medical Research and Opinion, 12/11/09

Economic consequences of ACS-related rehospitalizations in the US
Current Medical Research and Opinion, 12/10/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address